John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.

John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.

The QIMR Berghofer Institute is appealing for donations to help fast-track clinical trials for a new anti-inflammatory protein that can now be synthesised.

The protein is proving effective to treat asthma and could potentially work to treat a range of other conditions including hay fever, food allergies, and even coeliac.